Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1998-11-09
2000-07-18
Geist, Gary
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
548412, 548537, A01N 4336, C07F 932, C07D20732
Patent
active
060908416
ABSTRACT:
Substituted pyrrole derivatives of Formula I are antagonists of VLA-4 and/or .alpha..sub.4 .beta..sub.7, and as such are useful in the inhibition or prevention of cell adhesion and cell-adhesion mediated pathologies. These compounds may be formulated into pharmaceutical compositions and are suitable for use in the treatment of asthma, allergies, inflammation, multiple sclerosis, and other inflammatory and autoimmune disorders.
REFERENCES:
patent: 5510332 (1996-04-01), Kogan et al.
patent: 5605925 (1997-02-01), Martin et al.
Schroff, Hitesh N., et als. Bioorganic & Medicinal Chemistry Letters vol. 6, No. 21 pp. 2495-2500 (1996).
Jackson, David Y. et als. Med. Chem., 40 pp. 3359-3368 (1997).
Artico, et al., Pyrryl Aryl Sulfones. Arch Pharm., vol. 328, No. 3, pp. 223-229, 1995.
Chang Linda
Hagmann William K.
Maccoss Malcolm
Geist Gary
Keating Dominic
Merck & Co. , Inc.
Rose David L.
Yang Mollie M.
LandOfFree
Substituted pyrrole derivatives as cell adhesion inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Substituted pyrrole derivatives as cell adhesion inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Substituted pyrrole derivatives as cell adhesion inhibitors will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2037544